Evidence map›Paper›PMID 22806943›Full record

ArticleHepatology (Baltimore, Md.)2013

Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B.

Simon P Fletcher, Daniel J Chin, Donavan T Cheng, Palanikumar Ravindran, Hans Bitter, Lore Gruenbaum, Paul J Cote, Han Ma, Klaus Klumpp, Stephan Menne

Open access · greenAbstract readComparative Study
In one paragraph

Article in Hepatology (Baltimore, Md.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Simon P FletcherHoffmann-La Roche, Nutley, NJ, USA. Simon.Fletcher@gilead.com
Daniel J Chin
Donavan T Cheng
Palanikumar Ravindran
Hans Bitter
Lore Gruenbaum
Paul J Cote
Han Ma
Klaus Klumpp
Stephan Menne
La Roche College · USGeorgetown University · USGeorgetown University Medical Center · US

Funding

ANIMAL MODEL EVALUATION OF CANDIDATE HEPATITIS THERAPIESN01AI005399 · NIAID · CORNELL UNIVERSITY ITHACA · PI TENNANT, BUD C · 2000 to 2000
$1.4M
Phage-mediated bioluminescent detection of Yersinia pestisR44AI082698 · NIAID · GUILD ASSOCIATES, INC. · PI SCHOFIELD, DAVID A · 2011 to 2012
$705k
Phage-mediated bioluminescent detection of Yersinia pestis.R43AI082698 · NIAID · GUILD ASSOCIATES, INC. · PI SCHOFIELD, DAVID A · 2009 to 2009
$111k
NIAID NIH HHS N01 AI005399NIAID NIH HHS N01-AI-45179NIAID NIH HHS N01-AI-82698NIAID NIH HHS R43 AI082698NIAID NIH HHS R44 AI082698PHS HHS N01-95390
6 · The paper itself

Abstract

unlabelledThe woodchuck model of hepatitis B virus (HBV) infection displays many characteristics of human infection and has particular value for characterizing the host immune responses during the development of chronic infection. Using the newly developed custom woodchuck microarray platform, we compared the intrahepatic transcriptional profiles of neonatal woodchucks with self-limiting woodchuck hepatitis virus (WHV) infection to those woodchucks progressing to persistent WHV infection. This revealed that WHV does not induce significant intrahepatic gene expression changes during the early-acute stage of infection (8 weeks), suggesting it is a stealth virus. At the mid-acute phase of infection (14 weeks), resolution was associated with induction of a prominent cytotoxic T-cell signature. Strikingly, this was accompanied by high-level expression of PD-1 and various other inhibitory T-cell receptors, which likely act to minimize liver damage by cytotoxic T cells during viral clearance. In contrast to the expression of perforin and other cytotoxic effector genes, the interferon-γ (IFN-γ) signaling response in the mid-acute phase was comparable to that in chronically infected adult animals. The absence of a strong IFN-α/β transcriptional response indicated that type I IFN is not a critical mediator of self-limiting infection. Nevertheless, a number of antiviral genes, including viperin, were differentially expressed during resolving infection, suggesting that a subset of IFN-stimulated genes (ISG) may play a role in the control of WHV replication.

conclusionWe identified new immune pathways associated with the clearance of hepadnavirus infection revealing novel molecular targets with potential for the therapeutic treatment of chronic hepatitis B.

Indexed as

AnimalsAnimals, NewbornChronic DiseaseDisease Models, AnimalHepatitis BHepatitis B Virus, WoodchuckInterferon Regulatory Factor-1LiverMarmotaT-Lymphocytes, CytotoxicInterferon Regulatory Factor-1

Identifiers

PMID22806943
PMCPMC3525799
OpenAlexW2171393763

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.